Figure 1.

Differences in UBA7 expression according to clinicopathological characteristics. (A) UBA7 expression was lower in breast cancer tissues compared with that in normal tissues. Expression was significantly associated with (C) vital status, (D) tumor classification, (F) metastasis classification, (I) histological type and (K) gender. However, no significant association was observed with regard to (B) clinical stage, (E) N classification, (G) lymph node status, (H) margin status, (J) sample type and (L) age. UBA7, ubiquitin-like modifier-activating enzyme 7; T, tumor; M, metastasis.